AllianceBernstein
TEVA icon

AllianceBernstein’s Teva Pharmaceuticals TEVA Stock Holding History

AllianceBernstein’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
337,108
+140,041
+71% +$4.66M ﹤0.01% 1195
2026
Q1 		$6.15M Sell
197,067
-1,451
-0.7% -$46.7K ﹤0.01% 1438
2025
Q4 		$6.2M Sell
198,518
-9,033
-4% -$223K ﹤0.01% 1436
2025
Q3 		$4.19M Buy
207,551
+31,441
+18% +$552K ﹤0.01% 1599
2025
Q2 		$2.95M Sell
176,110
-8,016
-4% -$129K ﹤0.01% 1738
2025
Q1 		$2.83M Buy
184,126
+8,698
+5% +$155K ﹤0.01% 1717
2024
Q4 		$3.87M Sell
175,428
-18,274
-9% -$332K ﹤0.01% 1613
2024
Q3 		$3.49M Sell
193,702
-24,833
-11% -$435K ﹤0.01% 1689
2024
Q2 		$3.55M Buy
218,535
+2,801
+1% +$43.1K ﹤0.01% 1642
2024
Q1 		$3.04M Sell
215,734
-2,565
-1% -$32.3K ﹤0.01% 1692
2023
Q4 		$2.28M Sell
218,299
-9,093
-4% -$84.9K ﹤0.01% 1869
2023
Q3 		$2.32M Sell
227,392
-8,235
-3% -$76.7K ﹤0.01% 1801
2023
Q2 		$1.77M Sell
235,627
-2,218
-0.9% -$18K ﹤0.01% 1967
2023
Q1 		$2.1M Sell
237,845
-10,276
-4% -$102K ﹤0.01% 1834
2022
Q4 		$2.26M Sell
248,121
-13,510
-5% -$118K ﹤0.01% 1832
2022
Q3 		$2.11M Buy
261,631
+4,066
+2% +$36K ﹤0.01% 1852
2022
Q2 		$1.94M Buy
257,565
+990
+0.4% +$8.63K ﹤0.01% 1972
2022
Q1 		$2.41M Sell
256,575
-413,407
-62% -$3.45M ﹤0.01% 1976
2021
Q4 		$5.37M Buy
669,982
+387,389
+137% +$3.5M ﹤0.01% 1584
2021
Q3 		$2.75M Sell
282,593
-711
-0.3% -$6.66K ﹤0.01% 1974
2021
Q2 		$2.81M Sell
283,304
-7,412
-3% -$78.5K ﹤0.01% 1974
2021
Q1 		$3.35M Sell
290,716
-8,462
-3% -$97K ﹤0.01% 1798
2020
Q4 		$2.89M Sell
299,178
-30,333
-9% -$291K ﹤0.01% 1782
2020
Q3 		$2.97M Buy
329,511
+5,903
+2% +$62.4K ﹤0.01% 1626
2020
Q2 		$3.99M Sell
323,608
-48,664
-13% -$550K ﹤0.01% 1453
2020
Q1 		$3.34M Buy
372,272
+33,330
+10% +$341K ﹤0.01% 1380
2019
Q4 		$3.32M Sell
338,942
-1,007
-0.3% -$8.99K ﹤0.01% 1663
2019
Q3 		$2.34M Sell
339,949
-6,686,351
-95% -$51.2M ﹤0.01% 1830
2019
Q2 		$64.9M Sell
7,026,300
-5,878,746
-46% -$70.9M 0.04% 463
2019
Q1 		$202M Buy
12,905,046
+3,638,152
+39% +$64.2M 0.13% 151
2018
Q4 		$143M Sell
9,266,894
-187,945
-2% -$3.85M 0.11% 188
2018
Q3 		$204M Buy
9,454,839
+2,291,171
+32% +$53.2M 0.13% 155
2018
Q2 		$174M Sell
7,163,668
-188,839
-3% -$3.85M 0.12% 170
2018
Q1 		$126M Sell
7,352,507
-143,652
-2% -$2.8M 0.09% 222
2017
Q4 		$142M Sell
7,496,159
-5,058,097
-40% -$76.1M 0.1% 195
2017
Q3 		$221M Buy
12,554,256
+1,154,856
+10% +$26M 0.17% 133
2017
Q2 		$379M Buy
11,399,400
+2,782,257
+32% +$86.1M 0.29% 80
2017
Q1 		$277M Buy
8,617,143
+587,286
+7% +$20M 0.22% 106
2016
Q4 		$291M Buy
8,029,857
+5,735,176
+250% +$229M 0.24% 93
2016
Q3 		$106M Buy
+2,294,681
New +$120M 0.09% 230
2016
Q2 		– Sell
-1,579,351
Closed -$84.5M – 2991
2016
Q1 		$84.5M Sell
1,579,351
-1,384,672
-47% -$81.2M 0.07% 293
2015
Q4 		$195M Sell
2,964,023
-231,314
-7% -$14.3M 0.17% 140
2015
Q3 		$180M Buy
3,195,337
+381,242
+14% +$24.7M 0.15% 150
2015
Q2 		$166M Buy
2,814,095
+918,910
+48% +$56.7M 0.14% 164
2015
Q1 		$118M Buy
1,895,185
+1,031,434
+119% +$60M 0.1% 222
2014
Q4 		$49.7M Buy
863,751
+683,585
+379% +$38.1M 0.04% 468
2014
Q3 		$9.68M Sell
180,166
-1,036
-0.6% -$54.9K 0.01% 886
2014
Q2 		$9.5M Sell
181,202
-68,073
-27% -$3.48M 0.01% 904
2014
Q1 		$13.2M Buy
249,275
+65,841
+36% +$3.04M 0.01% 778
2013
Q4 		$7.35M Sell
183,434
-70,446
-28% -$2.77M 0.01% 954
2013
Q3 		$9.59M Sell
253,880
-8,018
-3% -$313K 0.01% 831
2013
Q2 		$10.3M Buy
+261,898
New +$10.2M 0.01% 792

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

AllianceBernstein's TEVA Position: Q2 2026 in Review

AllianceBernstein increased its Teva Pharmaceuticals (TEVA) stake by 71% in Q2 2026, buying an estimated $4.66M and bringing the position to 337,108 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1195.

AllianceBernstein first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $379M in Q2 2017. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • AllianceBernstein held 337,108 shares of Teva Pharmaceuticals worth $10.2M as of Q2 2026.
  • AllianceBernstein bought 140,041 Teva Pharmaceuticals shares in Q2 2026, an estimated $4.66M.
  • Teva Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1195 holding.
  • AllianceBernstein first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • AllianceBernstein's Teva Pharmaceuticals position peaked at $379M in Q2 2017.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.